You are here

Media Coverage

November 26, 2018
Good Morning America

Jennifer Doudna expresses concern that a scientist claiming to have created the first gene-edited babies broke from the international consensus within the scientific community calling for an open and transparent approach for any clinical use of human embryo editing.

In its weekly health care digest, the San Francisco Business Times highlights the new laboratory set up at Gladstone by Seth Shipman, whose work combines synthetic biology, genetics and neuroscience.

November 8, 2018
NIH Director's Blog

In his blog, NIH Director Francis Collins describes work by Bruce Conklin. He and his colleagues at UC Berkeley developed a new model that can mimic different degrees of stress that the heart may experience, for example, during exercise or in a person with high blood pressure.

October 23, 2018
Medium / UCSF Magazine

This post on Medium describes efforts at Gladstone by Jennifer Doudna and Bruce Conklin to bring CRISPR genome editing tools into the clinic to cure disease using an approach coined “genome surgery.”

October 15, 2018
The Washington Post

Many scientists are urging a halt to clinical trials that were based partly on falsified data published by a prominent researcher from Harvard Medical School. Deepak Srivastava comments to The Washington Post that it’s time to pause and evaluate such trials.

October 15, 2018
The New York Times

As a story broke out of Harvard Medical School and Brigham and Women’s Hospital involving the falsification of scientific data by Piero Anversa, Benoit Bruneau remarked to The New York Times that this could put into question an entire field of study.

October 9, 2018
CBS New York

CBS New York covers a breakthrough by Yadong Huang, who’s looking at a gene—called apoE4—he and his team believe increases the risk for developing Alzheimer's.

September 24, 2018
The Stem Cellar, CIRM

This blog post highlights a CIRM-funded scientific collaboration between UC Berkeley and Bruce Conklin at Gladstone, during which the researchers found a better way to study certain heart diseases by generating a 3D model of heart tissue.

September 20, 2018
San Francisco Business Times

The San Francisco Business Times explores the latest approaches to an HIV cure by companies and academic researchers. “‘Cure’ overpromises what we can do right now. But the idea of a cure has helped to shape the field,” says Warner Greene.

September 13, 2018

In this Time Magazine article that dives into new possible stem cell and regenerative therapies, Deepak Srivastava talks about his research and how stem cells offer a new way to get to the root cause of a disease and start looking for cures.